Form 4 for MRNA Moderna
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001127602-23-009743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-10 | 2023-03-08+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-10 | 2023-03-08+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $140.29 | -80.0K | 5.41M | -1% | -$11.22M |
| DM | 2023-03-10 | 2023-03-08+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.00 | -80.0K | 1.23M | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-08 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-08 | S | D | 26,018 | $141.18 | 5,425,928 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.54 to $141.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-03-09 | S | D | 2,109 | $142.26 | 5,411,946 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.88 to $142.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2023-03-09 | S | D | 9,232 | $141.30 | 5,414,055 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.84 to $141.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2023-03-09 | S | D | 5,563 | $140.23 | 5,423,287 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.82 to $140.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2023-03-09 | S | D | 3,896 | $139.24 | 5,428,850 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.65 to $139.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2023-03-09 | S | D | 7,739 | $137.97 | 5,432,746 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.61 to $138.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2023-03-09 | S | D | 11,461 | $137.25 | 5,440,485 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.60 to $137.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2023-03-09 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 10 | Common | Common Stock | 2023-03-08 | S | D | 13,982 | $141.76 | 5,411,946 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.55 to $141.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 11 | Derivative | Stock Option (Right to Buy) | 2023-03-08 | M | D | 40,000 | $0.00 | 1,267,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F12) This option is fully vested and exercisable. |
| 12 | Derivative | Stock Option (Right to Buy) | 2023-03-09 | M | D | 40,000 | $0.00 | 1,227,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F12) This option is fully vested and exercisable. |